Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Compound. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111620793B details a copper-catalyzed asymmetric trifluoromethyl cyanation method offering high enantioselectivity and mild conditions for reliable pharmaceutical intermediate manufacturing.
Patent CN112679290B reveals a cost-effective nickel-catalyzed asymmetric hydroalkynylation for AMG 837 intermediates, offering superior enantioselectivity and mild conditions.
Novel nickel catalyzed method enables room temperature synthesis of high purity chiral trifluoromethyl compounds offering significant supply chain and cost advantages for pharmaceutical intermediates manufacturing.
Patent CN112608274A reveals a novel Pd-catalyzed route for chiral amines. Discover cost reduction in chiral amine manufacturing and scalable supply chain solutions.
Patent CN105585516B reveals advanced palladium catalysis for high-purity pharmaceutical intermediates. Achieve substantial cost reduction and supply chain reliability.
Patent CN107188874A reveals efficient Cu-catalyzed Michael addition. High ee, mild conditions for pharma intermediates.
Novel asymmetric hydrogenation ligand CN120484023A ensures high ee and scalable production for pharmaceutical intermediates manufacturing supply chains.
Patent CN114957030B reveals Rhodococcus erythropolis AJ270 catalyzed hydrolysis for high-purity chiral intermediates, offering cost reduction and supply chain reliability.
Patent CN116023401B reveals mild photoredox synthesis for chiral borates. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN116947580A enables high-yield axially chiral compound production. Offers supply chain reliability and cost reduction in fine chemical manufacturing for global partners.
Patent CN107899611A enables visible light asymmetric hydroxylation using molecular oxygen. Delivers cost reduction and supply chain reliability for agrochemical intermediate manufacturing.
Patent CN117384177A reveals efficient Cu-catalyzed synthesis. Offers cost reduction and high purity for pharmaceutical intermediate manufacturing supply chains.
Patent CN106146306A reveals a metal-free organocatalytic route for axial chiral biaryl compounds, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN102212041A details a cost-effective synthesis of chiral cyclic beta-amino aryl butyric acid derivatives with high optical purity suitable for pharmaceutical manufacturing.
Patent CN107522585B details a mild transfer hydrogenation method for quinoline resolution. Achieves 99% ee with organocatalysis, offering cost-effective and scalable chiral intermediate manufacturing.
Novel enzymatic resolution method for chiral spiro compounds. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Patent CN116947643B reveals Rh-catalyzed resolution for high-purity axial chiral compounds offering supply chain stability and cost efficiency for global pharmaceutical intermediates manufacturing partners.
Patent CN114105822A reveals high-yield iridium-catalyzed synthesis of pseudo-C2 symmetric chiral diallyl compounds, offering superior enantioselectivity for pharmaceutical and agrochemical manufacturing.
Patent CN101962391B discloses a novel chiral phosphine catalyst offering high enantioselectivity for nitrile cyanosilylation, ensuring reliable supply chain solutions.
Patent CN105330608A reveals high-ee urazole synthesis. Enables cost reduction in chiral catalyst manufacturing and reliable supply chain for pharma intermediates.